Connect with us

Hi, what are you looking for?

Jewish Business News

Entertainment

Hilarious: Seth Meyers’ Closer Look into Trump’s hydroxychloroquine claims

Seth Meyers in Tuesday night’s A Closer Look took the viewers a hilarious journey into Donald Trump’s head. The president claimes that he’s taking an anti-malaria medication hydroxychloroquine, as a preventative treatment for coronavirus despite a deficiency of evidence for cure or even warnings of severe side effects.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.

“I’m really having a hard time wrapping my head around this,” said Meyers, “either [his doctors] gave him hydroxychloroquine or he’s lying about taking it, and honestly, I’m not sure which is more psychotic.”

Trump’s original thoughts on whether flu vaccines to household disinfectants might be effective against COVID-19 or Trump’s vitamin was “personalized” based on a mailed-in urine sample made the Late Night host joke: “You gotta be careful, man. People your age get a lot of scam calls. It wouldn’t surprise me to find out the White House had a reverse mortgage on it.”

 

Newsletter



Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Entertainment

The Movie The Professional is what made Natalie Portman a Lolita.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.

Copyright © 2021 Jewish Business News